Malayan, Lorna M.

HRN: 28-52-83  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/11/2026
CEFTAZIDIME 1GM (VIAL)
02/11/2026
02/18/2026
IV
2g
Q24
HAP
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines